Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Avanir signs letter of intent with IriSys for ALS drug

Feb. 10, 1999

Neuroprotective effects of FK-506 in rat stroke model not mediated by suppression of NO production

Feb. 9, 1999

Animal study supports cognition-enhancing efficacy of nefiracetam following ischemia

Feb. 9, 1999

NIH researchers determine 3-D structure of melatonin enzyme

Feb. 9, 1999

IOCM approves Rebif for MS

Feb. 9, 1999

UCB files NDA for levetiracetam

Feb. 8, 1999

Preclinical profile of novel antimigraine agent SB-220453 described

Feb. 8, 1999

Lubeluzole shows good safety but no efficacy in large trial in acute stroke patients

Feb. 8, 1999

Ex vivo studies explain disappointing results with antiadhesion therapy in stroke patients

Feb. 8, 1999

Merck researchers design tachykinin antagonists particularly useful as antiemetics

Feb. 8, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...